Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
New Recommendations on Use of Medtronic HVAD Heart Systems Issued For Patients With The Implant Medtronic HVAD Heart Systems were linked to 3,000 deaths, according to FDA records, and the manufacturer removed it from the market in 2021. However, many individuals still have the heart device implanted in their body. November 18, 2022 Irvin Jackson Add Your Comments Following thousands of reported deaths and a number of recalls issued in recent years, federal regulators have issued a series of new recommendations for individuals with an implanted Medtronic Heartwear Ventricular Assist Device (HVAD), which was removed from the market in 2021. The Medtronic HVAD was previously used for individuals at risk of death from end-stage left ventricular heart failure, involving an implanted medical device intended to help pump blood from the heart to the rest of the body. Typically the pump has been used while individuals are waiting for a heart transplant, but the HVAD has been plagued with problems. While there are many life-saving benefits of Medtronic’s HVAD mobility, the devices have been subject to at least 17 Class I recalls over defective components since they were approved by the FDA in November 2012, and the agency removed the HVAD from the market in June 2021, after identifying more than 3,000 report involving patient deaths. However, federal health officials do not recommend doctors remove the HVAD, unless an individual is experiencing problems. Therefore, many individuals face continuing risks from the device. Stay Up-to-Date About Medtronic MiniMed Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Medtronic MiniMed lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Medtronic MiniMed Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Medtronic MiniMed lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More On November 17, the FDA gave patients and healthcare professionals a list of new recommendations for HVAD systems. “Choosing to remove an implanted Medtronic Heartware Ventricular Assist Device (HVAD) System without a medically necessary reason is not recommended at this time,” the FDA recommendations state. “The risks associated with removing an implanted Medtronic HVAD System are higher than the potential benefits. Decisions about removing or exchanging the Medtronic HVAD System should be made by patients and health care providers together, considering the patient’s clinical status and surgical risks.” The FDA’s recommendations for patients included keeping their VAD coordinator aware of any concerns with the devices’ behavior, such as alarms, damage, power and battery issues, and even carrying case wear. It recommends they keep two sources of power connected to their controller at all times and to carry spare batteries, and a backup controller at all times. Many of the recommendations for patients involve taking extreme care in handling, replacing, and monitoring of batteries and other power sources. The FDA indicates Medtronic will be allowed to continue to make replacement components for the devices, despite the recall. The FDA is calling on doctors to make sure their HVAD patients are aware of those recommendations, as well as to be aware of the numerous communications, and medical device corrections Medtronic has released recently, such as modified software being available for backup controllers in case the primary controller fails. The agency also recommends doctors check the device for wear and damage during clinical visits, and urges them to report any adverse or suspected events to the FDA’s MedWatch Adverse Event Reporting System. Medtronic HVAD Problems Last summer, the FDA announced Medtronic was removing its HVAD systems from the market, due to an unreasonable risk of neurological events and increased death rates among patients. However, many individuals still have the device implanted, and the FDA does not recommend they have the Medtronic HVAD removed at the time, if there were no problems detected. According to an August 2021 investigation by ProPublica, FDA inspectors began voicing concerns about Medtronic HVAD systems as early as January 2014, following a HeartWare recall in late December 2013, which was issued because the device could fail and stop pumping, leading to serious injury and death. FDA investigators issued a warning letter a month later, after identifying a number of deficiencies at the HeartWare manufacturing facility in Miami Lakes, Florida, particularly involving the process for making sure that some corrections made to the HVAD actually work. The ProPublica investigation lay the blame at the FDA’s feet, saying the agency allowed more than 19,000 patients to be implanted with the heart pump, most of whom received their implants after the FDA had determined the HVAD did not meet federal safety standards. When the devices were removed from the market in June 2021, the FDA indicated it had received more than 3,000 reports of patient deaths by the end of 2020, all linked to HeartWare implant problems. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Heart Transplant, HeartWare, HVAD, Medical Device Recall, Medtronic More Medtronic MiniMed Lawsuit Stories Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks October 7, 2024 FDA Issues “Do Not Use” Warning for Recalled Medtronic NIM Endotracheal Tubes July 10, 2024 Medfusion Syringe Pump Recall Issued Over Software Errors March 6, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES DraftKings Micro-Betting Causes Addiction Risks in Vulnerable Users, Critics Warn (Posted: today) Lawsuits over gambling addictions are being brought against DraftKings, as regulators and health experts warn the platform’s push into micro-betting could heighten risks for vulnerable users. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Over $1,000 Bonus Bet Promo Dismissed by Federal Judge (08/01/2025)DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit (07/18/2025)FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling (07/08/2025) Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: yesterday) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025) Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 (Posted: 2 days ago) A federal judge has released a schedule of the first six Bard PowerPort bellwether trials, which will be held throughout 2026. MORE ABOUT: BARD POWERPORT LAWSUITVancomycin May Increase Risk of Midline Catheter Complications: Study (08/13/2025)Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (08/08/2025)Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025)
DraftKings Micro-Betting Causes Addiction Risks in Vulnerable Users, Critics Warn (Posted: today) Lawsuits over gambling addictions are being brought against DraftKings, as regulators and health experts warn the platform’s push into micro-betting could heighten risks for vulnerable users. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Over $1,000 Bonus Bet Promo Dismissed by Federal Judge (08/01/2025)DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit (07/18/2025)FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling (07/08/2025)
Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: yesterday) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025)
Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 (Posted: 2 days ago) A federal judge has released a schedule of the first six Bard PowerPort bellwether trials, which will be held throughout 2026. MORE ABOUT: BARD POWERPORT LAWSUITVancomycin May Increase Risk of Midline Catheter Complications: Study (08/13/2025)Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (08/08/2025)Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025)